SEC 13F Intelligence

Managers / Q1 2024 · view latest →

Valor Management LLC

CIK 0001846237 · 320 N. SANGAMON STREET, SUITE 1200, CHICAGO, IL, 60607 · (312) 683-1900

Reported Value
$480M
Q1 2024
Positions
6
Filings on Record
18
2019–present window
Filed
May 15, 2024
original filing

Summary

Valor Management LLC reported $480M in U.S.-listed holdings across 6 positions for Q1 2024.

The portfolio is heavily concentrated: HRMY alone accounts for 78.6% of reported value.

Compared with Q4 2023, the fund opened 3 new positions and exited 0.

Portfolio Metrics

Turnover
+0.0%
vs prior filed quarter
Largest Position
+78.6%
Harmony Biosciences

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’21: $627.7BQ4 ’21Q2 ’22: $567MQ3 ’22: $521MQ4 ’22: $634MQ4 ’22Q1 ’23: $380MQ2 ’23: $402MQ3 ’23: $372MQ3 ’23Q4 ’23: $364MQ1 ’24: $480MQ2 ’24: $455MQ2 ’24Q3 ’24: $475MQ4 ’24: $249MQ1 ’25: $241MQ1 ’25Q2 ’25: $238MQ3 ’25: $67MQ4 ’25: $55MQ4 ’25Q1 ’26: $181Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 100.0%
  • Common Stock · 100.0% · $480M

Quarter-over-Quarter Changes full breakdown →

vs Q4 2023 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
RDDTReddit, Inc.NEW+1.34M1.34M+$66M$66M
ALABAstera Labs, Inc.NEW+446.2K446.2K+$33M$33M
ANROAlto Neuroscience, Inc.NEW+157.0K157.0K+$2M$2M
HRMYHarmony Biosciences Holdings IncHELD+011.22M+$14M$377M
SONDQSonder Holdings IncHELD+0476.3K$204,818$1M
GETRGetaround, Inc.HELD+031.7K+$2,282$9,729

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2024

6 positions
#IssuerClass% PortfolioValueShares
1HRMYHarmony Biosciences Holdings Inchistory →COM78.55%$377M11.22M
2RDDTReddit, Inc.history →CL A13.75%$66M1.34M
3ALABAstera Labs, Inc.history →COM6.90%$33M446.2K
4ANROAlto Neuroscience, Inc.COM SHS0.50%$2M157.0K
5SONDQSonder Holdings IncCL A0.29%$1M476.3K
6GETRGetaround, Inc.COM0.00%$9,72931.7K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$181M5May 13, 202613F-HRchanges · EDGAR ↗
Q4 2025$55M3Feb 13, 202613F-HRchanges · EDGAR ↗
Q3 2025$67M4Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$238M4Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$241M4May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$249M4Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$475M4Nov 12, 202413F-HRchanges · EDGAR ↗
Q2 2024$455M6Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$480M6May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$364M3Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$372M4Nov 13, 202313F-HRchanges · EDGAR ↗
Q2 2023$402M5Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$380M4May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$634M4Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$521M3Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$567M3Aug 11, 202213F-HRchanges · EDGAR ↗
Q1 2022Under review4May 13, 202213F-HRchanges · EDGAR ↗
Q4 2021$627.7B4Feb 9, 202213F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.